Preface

Preface Publisher

Rezaei N^{1, 2, 3} ; Keshavarzfathi M^{1, 4, 5}

Show Affiliations

1. Research Center for Immunodeficiencies, Childrenâ€™s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
2. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3. Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran
4. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
5. Cancer Immunology Project (CIP), Universal Scientific Education and Research Network (USERN), Tehran, Iran

Source: Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives Published:2019

[No abstract available]

Style	Citing Format
MLA	Rezaei N, Keshavarzfathi M. "Preface." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, vol. , no. , 2019, pp. xiii-xiii.
APA	Rezaei N, Keshavarzfathi M (2019). Preface. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), xiii-xiii.
Chicago	Rezaei N, Keshavarzfathi M. "Preface." Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives , no. (2019): xiii-xiii.
Harvard	Rezaei N, Keshavarzfathi M (2019) 'Preface', Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives, (), pp. xiii-xiii.
Vancouver	Rezaei N, Keshavarzfathi M. Preface. Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives. 2019;():xiii-xiii.
BibTex	@article{ author = {Rezaei N and Keshavarzfathi M}, title = {Preface}, journal = {Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives}, volume = {}, number = {}, pages = {xiii-xiii}, year = {2019} }
RIS	TY - JOUR AU - Rezaei N AU - Keshavarzfathi M TI - Preface JO - Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives VL - IS - SP - xiii EP - xiii PY - 2019 ER -